複製鏈接
請複製以下鏈接發送給好友

藍柯

(武漢大學病毒學國家重點實驗室主任)

鎖定
藍柯,主要從事病毒感染及致病機理研究,在卡波氏肉瘤病毒(KSHV)、新冠病毒(SARS-CoV-2)等方面做出了系統性、原創性的研究工作。2020年9月,獲“湖北省抗擊新冠肺炎疫情先進個人”稱號。 [2] 
現任武漢大學病毒學國家重點實驗室主任,武漢大學動物三級生物安全實驗室主任、武漢大學生命科學學院教授、武漢大學泰康生命醫學中心PI,博士生導師 [1]  [3] 
中文名
藍柯
畢業院校
重慶醫科大學
學位/學歷
博士
專業方向
病毒學
研究方向
腫瘤病毒感染與致瘤機制

藍柯人物履歷

藍柯教育經歷

1995-1998 重慶醫科大學病理生理學專業,獲醫學碩士學位
1998-2001 中南大學湘雅醫學院病理生理學專業,獲醫學博士學位

藍柯工作經歷

1994-1995 四川省屏山縣人民醫院,住院醫師
2002-2006 美國賓夕法尼亞大學醫學院,博士後
2006-2016 中國科學院上海巴斯德研究所研究員,博士生導師,腫瘤病毒研究組組長,病原診斷技術研發中心主任
2011-2016 中國科學院上海巴斯德研究所副所長,紀委書記
2017- 武漢大學病毒學國家重點實驗室主任,武漢大學醫學研究院副院長,生命科學學院教授、博士生導師

藍柯學術兼職

Journal of Virology、Viruses編委,Journal of Medical Virology、Virologica Sinica、Science Bulletin副主編、Cell Insight執行主編、中國微生物學會病毒專委會副主委、湖北省生物工程學會理事長等。

藍柯獲獎記錄

湖北省抗擊新冠肺炎疫情先進個人(2020年) [2] 
國家萬人計劃領軍人才(2016年)
上海市先進工作者(2015年)
上海領軍人才(2015年)
國家創新人才推進計劃中青年科技創新領軍人才(2015年)
國家傑出青年科學基金獲得者(2014年)
國務院政府特殊津貼獲得者(2011年)
中科院朱李月華優秀教師獎(2010年)
新世紀百千萬人才工程國家級人選(2009年)
上海市浦江人才計劃入選者(2008年)
中科院百人計劃入選者(2006年)
美國白血病和淋巴瘤學會Special Fellow Award(2006年)

藍柯主要成就

在Nature、New England Journal of Medicine、Molecular Cell、Nature Ecology Evolution、Science Translational Medicine、Science Advances、PLoS Pathogens、Journal of Virology、Cell Host Microbe、PNAS、Cell Research、Cancer Research等學術期刊發表論文120餘篇;入選科睿唯安全球高被引學者。 [3] 

藍柯研究概述

主要從事腫瘤皰疹病毒感染及致瘤機理研究。

藍柯代表論文

1.Bai L, Dong J, Liu Z, Rao Y, Feng P*,Lan K*. Viperin catalyzes methionine oxidation to promote protein expression and function of helicases.Sci Adv2019(5): eaax1031
2.Zhang F, Liang D, Lin X, Zou Z, Sun R, Wang X, Liang X, Kaye KM,Lan K*. NDRG1 facilitates the replication and persistence of Kaposi's sarcoma-associated herpesvirus by interacting with the DNA polymerase clamp PCNA.PLoS Pathog. 2019 Feb 27;15(2):e1007628
3.Yuan F, Gao ZQ, Majerciak V, Bai L, Hu ML, Lin XX, Zheng ZM*, Dong YH*,Lan K*. The crystal structure of KSHV ORF57 reveals dimeric active sites important for protein stability and function.PLoS Pathog. 2018 Aug 10;14(8):e1007232
4.Yuan F, Gao ZQ, Majerciak V, Bai L, Hu ML, Lin XX, Zheng ZM, Dong YH,Lan K*.The crystal structure of KSHV ORF57 reveals dimeric active sites important for protein stability and function.PLoS Pathog.2018 Aug 10;14(8):e1007232
5.Li G, Zhu Y, Shao D, Chang H, Zhang X, Zhou D, Gao Y,Lan K*, Deng Q*. Recombinant covalently closed circular DNA of hepatitis B virus induces long-term viral persistence with chronic hepatitis in a mouse model.Hepatology. 2018 Jan;67(1):56-70.
6.Wang X, Zou Z, Deng Z, Liang D, Zhou X, Sun R,Lan K*. Male hormones activate EphA2 to facilitate Kaposi's sarcoma-associated herpesvirus infection: Implications for gender disparity in Kaposi's sarcoma.PLoS Pathog. 2017 Sep 28;13(9):e1006580.
7.Zou Z, Meng Z, Ma C, Liang D, Sun R,Lan K*. Guanylate-binding protein 1 inhibits nuclear delivery of Kaposi's sarcoma-associated herpesvirus virions by disrupting formation of actin filament.J Virol.2017 Jul 27;91(16). pii: e00632-17
8.Lin X, Sun R, Zhang F, Gao Y, Bin L,Lan K*. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/sentrin Specific Peptidase 6 to Facilitate Latency Establishment.J Virol.2017 Aug 10;91(17). pii: e00806-17
9.Sun R, Tan X, Wang X, Wang X, Yang L, Robertson ES,Lan K*. Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues.PLoS Pathog.2017 Jan 24;13(1):e1006167
10.Li S, Hu H, He Z, Liang D, Sun R,Lan K*. Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway.PLoS Pathog.2016 Oct 19;12(10):e1005900
11.Hu H, Dong J, Liang D, Gao Z, Bai L, Sun R, Hu H, Zhang H, Dong Y,Lan K*. Genome-wide mapping of the binding sites and structural analysis of KSHV vIRF2 reveal it is a DNA-binding transcription factor.J Virol.2015 Nov 4;90(3):1158-68
12.Jia B, Guo M, Li G, Yu D, Zhang X,Lan K*, Deng Q*. Hepatitis B virus core protein sensitizes hepatocytes to tumor necrosis factor-induced apoptosis by suppression of the phosphorylation of mitogen-activated protein kinase kinase 7.J Virol. 2015 Feb 15;89(4):2041-51.
13.Zhao Q, Liang D, Sun R, Jia B, Xia T, Xiao H,Lan K*. Kaposi's sarcoma-associated herpesvirus-encoded replication and transcription activator impairs innate immunity via ubiquitin-mediated degradation of myeloid differentiation factor 88.J Virol. 2015 Jan;89(1):415-27
14.Hu H, Zhang H, Gao Z, Wang D, Liu G, Xu J,Lan K*, Dong Y*. Structure of the type VI secretion phospholipase effector Tle1 provides insight into its hydrolysis and membrane targeting.Acta Crystallogr D Biol Crystallogr. 2014 Aug;70(Pt 8):2175-85
15.Liang D , Hu H, Li S, Dong J, Wang X, Wang Y, He L, He Z, Gao Y, Gao S,Lan K*. Oncogenic Herpesvirus KSHV Hijacks BMP-Smad1-Id Signaling to Promote Tumorigenesis.PLoS Pathog. 2014 Jul 10;10(7):e1004253.
16.Qi Z, Li G, Hu H, Yang C, Zhang X, Leng Q, Xie Y, Yu D, Zhang X, Gao Y,Lan K*, Deng Q*. Recombinant Covalently Closed Circular Hepatitis B Virus DNA Induces Prolonged Viral Persistence in Immunocompetent Mice.J Virol. 2014 Jul;88(14):8045-56
17.Sun R, Liang D, Gao Y,Lan K*. Kaposi's Sarcoma-Associated Herpesvirus-Encoded LANA Interacts with Host KAP1 To Facilitate Establishment of Viral Latency.J Virol. 2014 Jul 1;88(13):7331-7344.
18.Han J, Wang L, Liu J, Jin M, Hao F, Zhang P, Zhang Z, Wen D, Wu X, Liu G, Ji L, Xu D, Zhou D, Leng Q,Lan K*, Zhang C*. Co-circulation of three HA and two NA subtypes of avian influenza viruses in Huzhou, China, April 2013: implication for the origin of the novel H7N9 virus.J Virol. 2014 Jun;88(11):6506-11
19.Wang X, He Z, Xia T, Li X, Liang D, Lin X, Wen H,Lan K*. Latency-Associated Nuclear Antigen of Kaposi Sarcoma-Associated Herpesvirus Promotes Angiogenesis through Targeting Notch Signaling Effector Hey1.Cancer Res. 2014 Apr 1;74(7):2026-37.
20.Wang Z, Zhu K, Bai W, Jia B, Hu H, Zhou D, Zhang X, Zhang X, Xie Y, Bourgine MM, Michel ML,Lan K*, Deng Q*. Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection.J Virol. 2014 Mar;88(5):3004-15.
21.Han J, Jin M, Zhang P, Liu J, Wang L, Wen D, Wu X, Liu G, Zou Y, Lv X, Dong X, Shao B, Gu S, Zhou D, Leng Q, Zhang C,Lan K. Epidemiological link between exposure to poultry and all influenza A(H7N9) confirmed cases in Huzhou city, China, March to May 2013.Euro Surveill. 2013 May 16;18(20). pii: 20481.
22.Han J, Niu F, Jin M, Wang L, Liu J, Zhang P, Xie B, Wu X, Wen D, Ji L, Liu G, Yang Z, Zhang C, Zhou D, Leng Q,Lan K*. Clinical presentation and sequence analyses of HA and NA antigens of the novel H7N9 viruses.Emerg Microbes Infect.2013 May;2(5):e23.
23.Xia T, Lévy L, Levillayer F, Jia B, Li G, Neuveut C, Buendia MA,Lan K*, Wei Y*.The Four and a Half LIM-only Protein 2 (FHL2) Activates Transforming Growth Factorβ(TGF-β) Signaling by Regulating Ubiquitination of the E3 Ligase Arkadia.J Biol Chem. 2013 Jan 18;288(3):1785-94.
24.Yang Y, Xia T, Li N, Zhang J, Yang Y, Cong W, Deng Q,Lan K*, Zhou W*. Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma.Protein Cell. 2013 Jan;4(1):71-81.
25.Lin X, Li X, Liang D,Lan K*. MicroRNAs and unusual small RNAs discovered in Kaposi's sarcoma-associated herpesvirusvirions.J Virol. 2012 Dec; 86(23): 12717-30.
26.Jin Y, He Z, Liang D, Zhang Q, Zhang H, Deng Q, Robertson ES,Lan K*. Carboxyl-Terminal Amino Acids 1052 to 1082 of the Latency-Associated Nuclear Antigen (LANA) Interact with RBP-Jκand Are Responsible for LANA-Mediated RTA Repression.J Virol. 2012 May;86(9):4956-69
27.Liang D, Lin X,Lan K. Looking at Kaposi's Sarcoma-Associated Herpesvirus-Host Interactions from a microRNA Viewpoint.Front Microbiol. 2011;2:271.
28.Liu Y, Sun R, Lin X, Liang D, Deng Q,Lan K*. Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5.J Virol. 2012 Feb; 86(3):1372-81.
29.Li X, Liang D, Lin X, Robertson ES,Lan K*. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen reduces interleukin-8 expression in endothelial cells and impairs neutrophil chemotaxis by degrading nuclear p65.J Virol. 2011 Sep;85(17):8606-15.
30.Qin Y, Li Y, Liu W, Tian R, Guo Q, Li S, Li H, Zhang D, Zheng Y, Wu L,Lan K*,Wang J*. Penicilliummarneffei-stimulated dendritic cells enhance HIV-1 trans-infection and promote viral infection by activating primary CD4+ T cells.PLoS One. 2011;6(11):e27609
31.Lin X, Liang D, He Z, Deng Q, Robertson ES,Lan K*. miR-K12-7-5p encoded by Kaposi's sarcoma-associated herpesvirus stabilizes the latent state by targeting viral ORF50/RTA.PLoS One. 2011 Jan 20;6(1):e16224.
32.Liang D, Gao Y, Lin X, He Z, Zhao Q, Deng Q,Lan K. A human herpesvirusmiRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKε.Cell Res. 2011 May;21(5):793-806.
33.Wang X, He B, Zhang Z, Liu T, Wang H, Li X, Zhang Q,Lan K, Lu X, Wen H*. Human herpesvirus-8 in northwestern China: epidemiology and characterization among blood donors.Virol J. 2010 Mar 17;7:62.
34.He Z, Liu Y, Liang D, Wang Z, Robertson ES,Lan K*. Cellular corepressor TLE2 inhibits replication-and-transcription- activator-mediated transactivation and lytic reactivation of Kaposi's sarcoma-associated herpesvirus.J Virol. 2010 Feb;84(4):2047-62.
35.Lan K, Murakami M, Bajaj B, Kaul R, He Z, Gan R, Feldman M, Robertson ES. Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor.Cancer Biol Ther. 2009 Nov;8(22):2136-43.
36.Liu Y, Cao Y, Liang D, Gao Y, Xia T, Robertson ES,Lan K*. Kaposi's sarcoma-associated herpesvirus RTA activates the processivity factor ORF59 through interaction with RBP-Jkappa and a cis-acting RTA responsive element.Virology. 2008 Oct 25;380(2):264-75.
37.Lan K, Verma SC, Murakami M, Bajaj B, Kaul R, Robertson ES. Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein.Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16287-92.
38.Lan K, Murakami M, Choudhuri T, Tsai DE, Schuster SJ, Wasik MA, and Robertson E. Detection of Epstein-Barr Virus in T-Cell Prolymphocytic Leukemia cells in vitro.J Clin Virol.2008;43:260-5.
39.Verma S,Lan K, Choudhuri T, Cotter MA, and Robertson E. An autonomous replicating element within the KSHV genome.Cell Host Microbe.2007 Aug 16;2(2):106-18.
40.Lan K, Choudhuri T, Murakami M, Kuppers DA, and Robertson E. Intracellular Activated Notch1 Is Critical for Proliferation of KSHV Associated B Lymphoma Cell Lines in vitro.J Virol. 2006, 80(13):6411-6419
41.Lan K, Murakami M, Choudhuri T, Kuppers D, and Robertson E. Intracellular Activated Notch1 Can Reactivate KSHV from Latency.Virology. 2006, 351:393-403.
42.Lan K, Kuppers D, Verma S, Sharma N, Murakami M, and Robertson E. Induction of KSHV Latency Associated Nuclear Antigen by the Lytic Transactivator RTA: A Novel Mechanism for Establishment of Latency.J Virol. 2005;79(12):7453-65
43.Lan K, Kuppers D, and Robertson E. KSHV Reactivation is Regulated by Interaction of LANA with RBP-Jk, the Major Downstream Effector of the Notch Signaling Pathway.J Virol.2005;79(6):3468-78
44.Lan K, Kuppers DA, Verma SC, and Robertson E. Kaposi’s Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Inhibits Lytic Replication by Targeting Rta: a Potential Mechanism for Virus-Mediated Control of Latency.J Virol. 2004;78: 6585-6594 [1] 
參考資料